BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Duarte JA, de Barros ALB, Leite EA. The potential use of simvastatin for cancer treatment: A review. Biomed Pharmacother 2021;141:111858. [PMID: 34323700 DOI: 10.1016/j.biopha.2021.111858] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
Number Citing Articles
1 Unnam S, Manjappa AS, Muddana Eswara BR, Salawi A, Gunti P. Liposomal Melphalan: Approach to obtain improved plasma stability, pharmacokinetics, and in vitro and in vivo anticancer efficacy in combination with liposomal simvastatin against mouse RPMI-8226 multiple myeloma model. Journal of Drug Delivery Science and Technology 2022;73:103479. [DOI: 10.1016/j.jddst.2022.103479] [Reference Citation Analysis]
2 Perkins EJ, Woolard EA, Garcia-reyero N. Integration of Adverse Outcome Pathways, Causal Networks and ‘Omics to Support Chemical Hazard Assessment. Front Toxicol 2022;4:786057. [DOI: 10.3389/ftox.2022.786057] [Reference Citation Analysis]
3 Saleem A, Akhtar N, Minhas MU, Mahmood A, Khan KU, Abdullah O. Highly Responsive Chitosan-Co-Poly (MAA) Nanomatrices through Cross-Linking Polymerization for Solubility Improvement. Gels 2022;8:196. [PMID: 35323309 DOI: 10.3390/gels8030196] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
4 Mangelinck A, Habel N, Mohr A, Gaspar N, Stefanovska B, Fromigué O. Synergistic Anti-Tumor Effect of Simvastatin Combined to Chemotherapy in Osteosarcoma. Cancers (Basel) 2021;13:5869. [PMID: 34831022 DOI: 10.3390/cancers13225869] [Reference Citation Analysis]
5 Sambamoorthy U, Manjappa AS, Eswara BRM, Sanapala AK, Nagadeepthi N. Vitamin E Oil Incorporated Liposomal Melphalan and Simvastatin: Approach to Obtain Improved Physicochemical Characteristics of Hydrolysable Melphalan and Anticancer Activity in Combination with Simvastatin Against Multiple Myeloma. AAPS PharmSciTech 2021;23:23. [PMID: 34907484 DOI: 10.1208/s12249-021-02177-6] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 2.0] [Reference Citation Analysis]
6 Meng X, Gao JZ, Gomendoza SMT, Li JW, Yang S. Recent Advances of WEE1 Inhibitors and Statins in Cancers With p53 Mutations. Front Med (Lausanne) 2021;8:737951. [PMID: 34671620 DOI: 10.3389/fmed.2021.737951] [Reference Citation Analysis]
7 Whitlon DS. Statins and hearing. Hearing Research 2022. [DOI: 10.1016/j.heares.2022.108453] [Reference Citation Analysis]